December 11, 2020
Food and Drug Administration (FDA)
News release
“At this time, data are not available to make a determination about how long the vaccine will provide protection, nor is there evidence that the vaccine prevents transmission of SARS-CoV-2 from person to person.”
Works of the United States government are not entitled to domestic copyright protection under U.S. law and are therefore in the public domain.
document
breakthrough cases,COVID-19,emergency use authorization (EUA),FDA approvals,manufacturers,vaccines